美国入境难民疫苗接种规划的比较成本分析
该研究比较了美国入境难民疫苗接种规划(VPR)实施前后两种情景下难民完成全程接种的成本,结果显示VPR情景在全部年龄组均节省成本,人均净节省225.93至498.42美元,且能降低难民入境时已感染疫苗可预防疾病的风险。
要点
- VPR情景在各年龄组均比无VPR情景节省接种成本。
- 人均净节省225.93美元(难民医疗援助/医疗补助支付)至498.42美元(私营部门支付)。
- 仅限VPR所含疫苗时,VPR情景人均成本降低56%。
核心结论
- VPR是一项节省成本的规划,同时能降低难民入境时已感染疫苗可预防疾病的风险。
研究设计与样本
- 研究量化并比较了两种情景下难民全程接种成本:无VPR基线情景和当前VPR情景。
- 按四个年龄分层组评估全程接种及VPR所含疫苗子集的成本,所有成本以2015年美元报告。
- 进行了单因素和概率敏感性分析及盈亏平衡分析以评估结果稳健性。
主要发现
- VPR情景下难民接种成本在所有 examined 年龄组均低于无VPR情景。
- 人均净节省范围从225.93美元(按难民医疗援助或医疗补助支付国内成本估算)到498.42美元(按私营部门支付估算)。
- 仅分析VPR所含疫苗时,按难民医疗援助/医疗补助支付,VPR情景人均平均成本降低56%。
- VPR情景的净节省对接种成本、国内疫苗覆盖率和再接种率等输入参数敏感,但在合理参数范围内VPR情景均节省成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccination Program for US-bound Refugees (VPR) currently provides one or two doses of some age-specific Advisory Committee on Immunization Practices (ACIP)-recommended vaccines to US-bound refugees prior to departure. METHODS: We quantified and compared the full vaccination costs for refugees using two scenarios: (1) the baseline of no VPR and (2) the current situation with VPR. Under the first scenario, refugees would be fully vaccinated after arrival in the United States. For the second scenario, refugees would receive one or two doses of selected vaccines before departure and complete the recommended vaccination schedule after arrival in the United States. We evaluated costs for the full vaccination schedule and for the subset of vaccines provided by VPR by four age-stratified groups; all costs were reported in 2015 US dollars. We performed one-way and probabilistic sensitivity analyses and break-even analyses to evaluate the robustness of results. RESULTS: Vaccination costs with the VPR scenario were lower than costs of the scenario without the VPR for refugees in all examined age groups. Net cost savings per person associated with the VPR were ranged from $225.93 with estimated Refugee Medical Assistance (RMA) or Medicaid payments for domestic costs to $498.42 with estimated private sector payments. Limiting the analyses to only the vaccines included in VPR, the average costs per person were 56% less for the VPR scenario with RMA/Medicaid payments. Net cost savings with the VPR scenario were sensitive to inputs for vaccination costs, domestic vaccine coverage rates, and revaccination rates, but the VPR scenario was cost savings across a range of plausible parameter estimates. CONCLUSIONS: VPR is a cost-saving program that would also reduce the risk of refugees arriving while infected with a vaccine preventable disease.
引用
- Joo H, Maskery B, Mitchell T, et al. A comparative cost analysis of the Vaccination Program for US-bound Refugees. Vaccine. 2017. PMID: 28919225. doi:10.1016/j.vaccine.2017.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。